Larvol Delta - VICTORIONLEAP-A-RealWorld-Study-of-LongTerm-Adherence-and-Persistence-to-Inclisiran-Evolocumab-and-Alirocumab

Leqvio (inclisiran) - Novartis

Praluent (alirocumab) - Sanofi, Regeneron

Repatha (evolocumab) - Amgen, Astellas

http://clinicaltrials.gov/ct2/show/NCT07543731

Jul 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next